The Centers for Medicare and Medicaid Services (CMS) launched its competitive bidding program for medical devices and equipment in 2009.

FORBES: The Federal Government's Deeply Flawed System For Controlling Medicare Costs

Analysts cheered a draft statement from the Centers for Medicare and Medicaid Services (CMS) that said the government plans to pay for prostate cancer treatment Provenge, made by Seattle-based biotechnology firm Dendreon.

FORBES: Provenge's Potential

To be fair, the Centers for Medicare and Medicaid Services (CMS) is trying to catch the fraud.

FORBES: Move up http://i.forbesimg.com t Move down